Inhibition of N-Terminal Lysines Acetylation and Transcription Factor Assembly by Epirubicin Induced Deranged Cell Homeostasis

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Khan, Shahper N ^a,c   Danishuddin, Mohd ^a   Varshney, Bhavna ^b   Lal, Sunil K ^b   Khan, Asad U ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

^b INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^c TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; EPIRUBICIN; HISTONE H3; LYSINE; TRANSCRIPTION FACTOR;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL CYCLE ARREST; CELL METABOLISM; CHROMATIN; COMPLEX FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BINDING SITE; DRUG DNA BINDING; DRUG PROTEIN BINDING; DRUG TARGETING; EMBRYO; ENERGY TRANSFER; HISTONE ACETYLATION; HUMAN; HUMAN CELL; MOLECULAR DOCKING; NONHUMAN; PROTEIN ASSEMBLY; PROTEIN DNA INTERACTION; THERMODYNAMICS; TRANSCRIPTION REGULATION;

ACETYLATION; BINDING SITES; CELL CYCLE CHECKPOINTS; CELL DEATH; CELL LINE; CELL MEMBRANE PERMEABILITY; CHROMATIN; DNA; EPIRUBICIN; HEK293 CELLS; HISTONES; HOMEOSTASIS; HUMANS; LYSINE; NUCLEOSOMES; SACCHAROMYCES CEREVISIAE; THERMODYNAMICS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84871309530     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051850     Document Type: Article

References (45)

1. Broggini M, D'Incalci M, (1994) Modulation of transcription factor-DNA interaction by anticancer drugs. Anticancer Drug Design 9: 373-387.
2. Khan SN, Khan AU, (2010) Role of histone acetylation in cell physiology and diseases: An update. Clin Chim Acta 411: 1401-1411.
3. Strahl BD, Allis CD, (2000) The language of covalent histone modifications. Nature 403: 41-45.
4. Luger K, Richmond TJ, (1998) The histone tails of the nucleosome. Curr Opin Genet Dev 8: 140-146.
5. Luger K, Mader AW, Richmond RK, Sargent DF, Richmond TJ, (1997) Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389: 251-260.
6. Gray SG, (2001) The BT. Histone acetylation/deacetylation and cancer: an "open" and "shut" case? Curr Mol Med 1: 401-429.
7. Gregory PD, Wagner K, Horz W, (2001) Histone acetylation and chromatin remodeling. Exp Cell Res 265: 195-202.
8. Clifford J, Chiba H, Sobieszczuk D, Metzger D, Chambon P, (1996) RXR alpha-null F9 embryonal carcinoma cells are resistant to the differentiation, anti-proliferative and apoptotic effects of retinoids. EMBO J 15: 4142-4155.
9. Haupt Y, Barak Y, Oren M, (1996) Cell type-specific inhibition of p53-mediated apoptosis by mdm2. EMBO J 15: 1596-1606.
10. Darzynkiewicz Z, Bruno S, Del Bino G, Gorczyca W, Hotz MA, et al. (1992) Features of apoptotic cells measured by flow cytometry. Cytometry 13: 795-808.
11. Munishkina LA, Fink AL, Uversky VN, (2004) Conformational prerequisites for formation of amyloid fibrils from histones. J Mol Biol 342: 1305-1324.
12. Miles JL, Morey E, Crain F, Gross S, San Julian JS, et al. (1962) Inhibition of alpha-chymotrypsin by diethyl ether and certain alcohols: a new type of competitive inhibition. J Biol Chem 237: 1319-1322.
13. Khan SN, Islam B, Yennamalli R, (2008) Sultan A, Subbarao N, et al. (2008) Characterization of doxorubicin binding site and drug induced alteration in the functionally important structural state of oxyhemoglobin. J Pharm Biomed Anal 48: 1096-1104.
14. F̈orster T, Sinanoglu O (1996) Modern Quantum Chemistry Vol 3, New York: Academic Press. 93p.
15. Hu YJ, Liu Y, Wang JB, Xiao XH, Qu SS, (2004) Study of the interaction between monoammonium glycyrrhizinate and bovine serum albumin. J Pharm Biomed Anal 36: 915-919.
16. Chen Y, Elangovan M, Periasamy A (2005) FRET data analysis: the algorithm. In: Periasamy A, Day RN, editors. Molecular Imaging: FRET Microscopy and Spectroscopy. Oxford: Oxford University Press. 126-145.
17. Ahmed-Ouameur A, Tajmir-Riahi HA, (2004) Structural analysis of DNA interactions with biogenic polyamines and cobalt(III)hexamine studied by Fourier transform infrared and capillary electrophoresis. J Biol Chem 279: 42041-42054.
18. Nafisi S, Sobhanmanesh A, Alimoghaddam K, Ghavamzadeh A, Tajmir-Riahi HA, (2005) Interaction of arsenic trioxide As2O3 with DNA and RNA. DNA Cell Biol 24: 634-640.
19. Sturm RA, Bisshop F, Takahashi H, Parsons PG, (1991) A melanoma octamer binding protein is responsive to differentiating agents. Cell Growth & Differentiation 2: 519-524.
20. Klemm JD, Rould MA, Aurora R, Herr W, Pabo CO, (1994) Crystal Structure of the Oct-1 POU Domain Bound to an Octamer Site: DNA Recognition with tethered DNA-Binding Modules. Cell 77: 21-32.
21. Thomson JAF, Parsons PG, Sturm RA, (1993) In vivo and in vitro expression of octamer binding proteins in human melanoma metastases, brain tissue, and fibroblasts. Pigment Cell Res 6: 13-22.
22. Liang SD, Marmorstein R, Harrison SC, Ptashne M, (1996) DNA sequence preferences of GAL4 and PPR1: How a subset of Zn2Cys6 binuclear cluster proteins recognizes DNA. Mol Cell Biol 16: 3773-3780.
23. Kessel D, (1979) Enhanced glycosylation induced by adriamycin. Mol Pharmacol 16: 306-312.
24. Rabbani A, Finn RM, Thambirajah AA, Ausió J, (2004) Binding of antitumor antibiotic daunomycin to histones in chromatin and in solution. Biochemistry 43: 16497-16504.
25. Koyama Y, Kikuchi S, Nakagawa S, Kobayashi S, (2007) Dissociation of DNA from histone by reaction of anti-cancer drug cis-diamminedichloroplatinum(II) with DNA-histone complexes used as cellular model. Chem Pharm Bull 55: 520-525.
26. Khan SN, Yennamalli R, Subbarao N, Khan AU, (2011) Mitoxantrone induced impediment of histone acetylation and structural flexibility of the protein. Cell Biochem Biophys 60: 209-218.
27. Umov FD, (2003) Chromatin as a tool for study of genome functions in cancer. Ann N Y Acad Sci 983: 5-21.
28. Mir MA, Das S, Dasgupta D, (2004) N-terminal tail domains of core histones in nucleosome block the access of anticancer drugs, mithramycin and daunomycin, to the nucleosomal DNA. Biophys Chem 109: 121-135.
29. Mahlknecht U, Hoelzer D, (2000) Histone acetylation modifiers in the pathogenesis of malignant disease. Mol Med 6: 623-644.
30. Liu Y, Hong Y, Zhao Y, Ismail TM, Wong Y, et al. (2008) Histone H3 (lys-9) deacetylation is associated with transcriptional silencing of E-cadherin in colorectal cancer cell lines. Cancer Invest 26: 575-582.
31. Murphree SA, Cunningham KM, Hwang AC, Sartorelli AC, (1976) Effects of adriamycin on surface properties of sarcoma 180 ascites cells. Biochem Pharmacol 25: 1227-1231.
32. Grana X, Reddy P, (1995) Cell cycle control in mammalian cells: Role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CDKIs). Oncogene 11: 211-219.
33. Schwartz GK, Shah MA, (2005) Targeting the cell cycle: A new approach to cancer therapy. J Clin Oncol 23: 9408-9421.
34. Gottesfeld JM, Turner JM, Dervan PB, (2000) Chemical approaches to control gene expression. Gene Exp 9: 77-91.
35. Priebe W, Fokt I, Przewloka T, Chaires JB, Portugal J, et al. (2001) Exploiting anthracycline scaffold for designing DNA-targeting agents. Methods Enzymol 340: 529-555.
36. Feng HP, Scherl DS, Widom J, (1993) Lifetime of the histone octamer studied by continuous-flow quasielastic light scattering: test of a model for nucleosome transcription. Biochemistry 32: 7824-7831.
37. Chen YH, Yang JT, (1971) A new approach to the calculation of secondary structures of globular proteins by optical rotatory dispersion and circular dichroism. Biochem Biophys Res Commun 44: 1285-1291.
38. Wang R, Lai L, Wang SJ, (2002) Further development and validation of empirical scoring functions for structure-based binding affinity prediction. Comput Aided Mol Des 16: 11-26.
39. Lakowicz JR, Weber G, (1973) Quenching of fluorescence by oxygen. Probe for structural fluctuations in macromolecules. Biochemistry 12: 4161-4170.
40. Gao H, Lei L, Liu J, Kong Q, Chen X, et al. (2004) The study on the interaction between human serum albumin and a new reagent with antitumour activity by spectrophotometric methods. J Photochem Photobiol Part A 167: 213-221.
41. Ponticelli AS, Struhl K, (1990) Analysis of saccharomyces cerevisiae his3 transcription In Vitro: Biochemical support for multiple mechanisms of transcription. Mol Cell Biol 10: 2832-2839.
42. Bradford MM, (1976) A Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
43. Larouche K, Bergeron MJ, Leclerc S, Guerin SL, (1996) Optimization of competitor poly(dI-dC).poly(dI-dC) levels is advised in DNA-protein interaction studies involving enriched nuclear proteins. Biotechniques 20: 439-444.
44. Tyagi S, Lal SK, (2000) Combined transformation and genetic technique verification of protein-protein interactions in the yeast two-hybrid system. Biochem Biophys Res Commun 277: 589-593.
45. Tyagi S, Korkaya H, Zafrullah M, Jameel S, Lal SK, (2002) The phosphorylated form of the ORF3 protein of hepatitis E virus interacts with its non-glycosylated form of the major capsid protein ORF2. J Biol Chem 277: 22759-22767.